Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis’ most-advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types, including locally advanced or metastatic urothelial cancer, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer. Aktis’ second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3 expressing tumors, including prostate, lung and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside of Aktis’ proprietary pipeline. Aktis Oncology is seeking a highly motivated Principal Scientist to support manufacturing and assay development of AKTIS Oncology’s proprietary radiopharmaceutical drug products. The Principal Scientist lead a small team of scientists and participate in the manufacturing and formulation optimization of Aktis’ clinical candidates within the RPD group and provide subject matter expert support of regulatory packages. This role is critical in ensuring product quality, regulatory compliance, and successful advancement of radiopharmaceutical programs from early development through clinical manufacturing phases. The position will collaborate closely with cross-functional team members to ensure timely delivery of robust manufacturing protocols in support of technology transfer activities. The ideal candidate has hands-on experience in radiolabeling and handling radioactive materials and radiopharmaceutical analytical techniques. This role requires full-time on-site presence at the Aktis Boston office.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal